Evidence map›Paper›PMID 41300076›Full record

ArticleFoods (Basel, Switzerland)2025

Consumer Interest in Alternative Grains, Especially Sorghum: A Qualitative Investigation.

Edgar Chambers, Edgar Chambers

Abstract read
In one paragraph

Article in Foods (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Edgar ChambersCenter for Sensory Analysis and Consumer Behavior, Kansas State University, Manhattan, KS 66506, USA.
Edgar ChambersCenter for Sensory Analysis and Consumer Behavior, Kansas State University, Manhattan, KS 66506, USA.ORCID 0000-0002-2480-0200

Funding

United States Department of Agriculture Hatch accession number 1016242
6 · The paper itself

Abstract

The market for niche and novelty products in the food industry is growing. However, breaking into the market is tough and reaching the modern-day consumer is harder than ever before. Sorghum, a so-called "ancient grain," has a chance to be able to compete, but its introduction to human food products needs to be done properly if it is to become a mainstream ingredient. Ten focus groups, with at least two in each of the United States (U.S.) census regions, were conducted to better understand the perceptions, opinions, beliefs, and attitudes for introducing new grain products to the market and specifically regarding grain sorghum. Participants were unfamiliar with sorghum. The few who had heard of sorghum before had difficulty recalling anything about it. When shown a fact sheet on a "new grain" and the nutrition information about the grain, the majority of responses were quite positive. Most consumers were interested in trying products made with the grain and provided various ways the grain (i.e., sorghum) could be introduced to consumers in the United States. A number of terms with potential positive connotations were mentioned by participants that could be used in future research to determine the specific marketability of the grain as an ingredient or in finished products. This qualitative market research demonstrates the open slate that groups such as sorghum commissions, industry, government, and consumer groups have related to sorghum use for consumer food products. It is important to give manufacturers ideas on how best to introduce this "new" grain and to determine which products people would like to see it in. It also is important to understand the marketing options people want to see for a food they have not tried before. Finally, what food advertising options consumers say they pay attention to and which they tend not to focus on is a focus of this research.

Indexed as

consumerfocus groupgrainmarketingqualitativesorghum

Identifiers

PMID41300076
PMCPMC12652303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.